Molecular biology articles within Oncogenesis

Featured

• Article
  25 January 2024 | Open Access

  LUBAC promotes angiogenesis and lung tumorigenesis by ubiquitinating and antagonizing autophagic degradation of HIF1α

  • Ying Jin
  • , Yazhi Peng
  •  & Jian Fu

• Article
  07 December 2023 | Open Access

  Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells

  • Li Ding
  • , Yujie Xu
  •  & Xinyue Zhang

• Article
  21 September 2023 | Open Access

  AIFM2 promotes hepatocellular carcinoma metastasis by enhancing mitochondrial biogenesis through activation of SIRT1/PGC-1α signaling

  • Sanxing Guo
  • , Fengying Li
  •  & Junqi Liu

• Review Article
  16 September 2023 | Open Access

  Discovery of neddylation E2s inhibitors with therapeutic activity

  • MAA Mamun
  • , Ying Liu
  •  & Hong-Min Liu

• Article
  12 April 2023 | Open Access

  PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability

  • Natalia Martínez
  • , Teresa Gragera
  •  & José M. Rojas-Cabañeros

• Article
  25 February 2023 | Open Access

  PELI1 and EGFR cooperate to promote breast cancer metastasis

  • Jie Qi
  • , Guangsen Xu
  •  & Baobing Zhao

• Article
  17 February 2023 | Open Access

  Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy

  • Fabio Vanoli
  • , Laurie Herviou
  •  & Cristina R. Antonescu

• Article
  10 October 2022 | Open Access

  Non-genetic stratification reveals epigenetic heterogeneity and identifies vulnerabilities of glycolysis addiction in lung adenocarcinoma subtype

  • Xuming Song
  • , Te Zhang
  •  & Feng Jiang

• Article
  17 September 2022 | Open Access

  PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma

  • Emma Phillips
  • , Jörg Balss
  •  & Violaine Goidts

• Article
  10 August 2022 | Open Access

  Tumor-derived miR-130b-3p induces cancer-associated fibroblast activation by targeting SPIN90 in luminal A breast cancer

  • Suyeon Ahn
  • , Ahreum Kwon
  •  & Woo Keun Song

• Article
  08 August 2022 | Open Access

  Methylation of HBP1 by PRMT1 promotes tumor progression by regulating actin cytoskeleton remodeling

  • Jiyin Wang
  • , Ruixiang Yang
  •  & Xiaowei Zhang

• Article
  04 August 2022 | Open Access

  ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1

  • Zhuo Shao
  • , Chenggang Li
  •  & Hua Fan

• Article
  20 July 2022 | Open Access

  The E3 ubiquitin ligase MG53 inhibits hepatocellular carcinoma by targeting RAC1 signaling

  • Xiaomin Ma
  • , Xiaoxiao Ma
  •  & Lihui Han

• Article
  18 July 2022 | Open Access

  NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis

  • Shounan Lu
  • , Shanjia Ke
  •  & Yong Ma

• Article
  11 July 2022 | Open Access

  MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms

  • Lap Hing Chi
  • , Ryan S. N. Cross
  •  & Robin L. Anderson

• Article
  24 June 2022 | Open Access

  Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma

  • Yunzhen Qian
  • , Yitao Gong
  •  & Chen Liu

• Article
  18 June 2022 | Open Access

  The TIP60-ATM axis regulates replication fork stability in BRCA-deficient cells

  • Emily M. Schleicher
  • , Ashna Dhoonmoon
  •  & George-Lucian Moldovan

• Article
  22 April 2022 | Open Access

  Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma

  • Ruth Berthold
  • , Ilka Isfort
  •  & Wolfgang Hartmann

• Article
  07 March 2022 | Open Access

  PSMC2 promotes the progression of gastric cancer via induction of RPS15A/mTOR pathway

  • Tao Liu
  • , Junling Zhang
  •  & Zhen Yang

• Article
  01 March 2022 | Open Access

  miR-32 promotes MYC-driven prostate cancer

  • Mauro Scaravilli
  • , Sonja Koivukoski
  •  & Leena Latonen

• Article
  19 January 2022 | Open Access

  Anti-miR-135/SPOCK1 axis antagonizes the influence of metabolism on drug response in intestinal/colon tumour organoids

  • Roya Babaei-Jadidi
  • , Hossein Kashfi
  •  & Abdolrahman S. Nateri

• Article
  23 October 2021 | Open Access

  ACTL6A suppresses p21^Cip1 tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype

  • Suruchi Shrestha
  • , Gautam Adhikary
  •  & Richard L. Eckert

• Article
  17 September 2021 | Open Access

  Post-transcriptional screen of cancer amplified genes identifies ERBB2/Her2 signaling as AU-rich mRNA stability-promoting pathway

  • Jenan Al-Matouq
  • , Latifa Al-Haj
  •  & Khalid S. A. Khabar

• Article
  06 August 2021 | Open Access

  E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression

  • Cheemala Ashok
  • , Neha Ahuja
  •  & Sanjeev Shukla

• Article
  13 July 2021 | Open Access

  CtBP1/2 differentially regulate genomic stability and DNA repair pathway in high-grade serous ovarian cancer cell

  • YingYing He
  • , Zhicheng He
  •  & Shubai Liu

• Article
  17 May 2021 | Open Access

  PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1

  • Lucas Schneider
  • , Stefanie Herkt
  •  & Joern Lausen

• Article
  04 May 2021 | Open Access

  Moderate DNA hypomethylation suppresses intestinal tumorigenesis by promoting caspase-3 expression and apoptosis

  • Xiaoya Duan
  • , Yuanyong Huang
  •  & Jiemin Wong

• Article
  30 April 2021 | Open Access

  The metastasis suppressor protein NM23-H1 modulates the PI3K-AKT axis through interaction with the p110α catalytic subunit

  • Francesco Paolo Pennino
  • , Masanao Murakami
  •  & Erle S. Robertson

• Article
  06 April 2021 | Open Access

  CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo

  • Laura Israël
  • , Anton Glück
  •  & Frédéric Bornancin

• Article
  17 March 2021 | Open Access

  C20orf204, a hepatocellular carcinoma-specific protein interacts with nucleolin and promotes cell proliferation

  • Sebastian Burbano De Lara
  • , Doan Duy Hai Tran
  •  & Teruko Tamura

• Article
  15 March 2021 | Open Access

  Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)

  • Petr Makhov
  • , Igor Bychkov
  •  & Yanis Boumber

• Article
  13 March 2021 | Open Access

  USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer

  • Fabiana Alejandra Rossi
  • , Juliana Haydeé Enriqué Steinberg
  •  & Mario Rossi

• Article
  05 March 2021 | Open Access

  RNF8 ubiquitinates RecQL4 and promotes its dissociation from DNA double strand breaks

  • Qunsong Tan
  • , Kaifeng Niu
  •  & Yongliang Zhao

• Article
  08 January 2021 | Open Access

  A novel role of MNT as a negative regulator of REL and the NF-κB pathway

  • Judit Liaño-Pons
  • , M. Carmen Lafita-Navarro
  •  & Javier León

• Article
  07 December 2020 | Open Access

  The HLTF–PARP1 interaction in the progression and stability of damaged replication forks caused by methyl methanesulfonate

  • Jia-Lin Shiu
  • , Cheng-Kuei Wu
  •  & Hungjiun Liaw

• Review Article
  31 October 2020 | Open Access

  The functional analysis of Cullin 7 E3 ubiquitin ligases in cancer

  • Le Shi
  • , Dongyue Du
  •  & Jiangang Long

• Article
  11 October 2020 | Open Access

  Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer

  • Sera Lim
  • , Yesol Kim
  •  & Jong Hoon Park

• Article
  30 September 2020 | Open Access

  Epigenetic activation of the small GTPase TCL contributes to colorectal cancer cell migration and invasion

  • Baoyu Chen
  • , Zhiwen Fan
  •  & Yong Xu

• Article
  28 September 2020 | Open Access

  Extracellular signal-regulated kinases associate with and phosphorylate DHPS to promote cell proliferation

  • Chao Wang
  • , Zhen Chen
  •  & Junjie Chen

• Article
  26 August 2020 | Open Access

  Methyl-CpG-binding protein 2 drives the Furin/TGF-β1/Smad axis to promote epithelial–mesenchymal transition in pancreatic cancer cells

  • Huizhi Wang
  • , Jie Li
  •  & Min Xu

• Article
  15 June 2020 | Open Access

  USP42 enhances homologous recombination repair by promoting R-loop resolution with a DNA–RNA helicase DHX9

  • Misaki Matsui
  • , Ryo Sakasai
  •  & Ryotaro Nishi

• Article
  10 June 2020 | Open Access

  Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma

  • Philip Weidner
  • , Michaela Söhn
  •  & Elke Burgermeister

• Article
  01 June 2020 | Open Access

  MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription

  • DongDong Tong
  • , Jing Zhang
  •  & Chen Huang

• Article
  04 May 2020 | Open Access

  MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics

  • Elena Vila-Navarro
  • , Elena Fernandez-Castañer
  •  & Meritxell Gironella

• Article
  13 February 2020 | Open Access

  CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer

  • Yanjun Li
  • , Huili Hu
  •  & Yaoqin Gong

• Article
  10 February 2020 | Open Access

  STAT3 activates MSK1-mediated histone H3 phosphorylation to promote NFAT signaling in gastric carcinogenesis

  • Hongyan Qi
  • , Zhiyi Yang
  •  & Jing Shen

• Article
  06 February 2020 | Open Access

  p73 – NAV3 axis plays a critical role in suppression of colon cancer metastasis

  • Apoorva Uboveja
  • , Yatendra Kumar Satija
  •  & Daman Saluja

• Article
  03 February 2020 | Open Access

  DNMT3A mutants provide proliferating advantage with augmentation of self-renewal activity in the pathogenesis of AML in KMT2A-PTD-positive leukemic cells

  • Rabindranath Bera
  • , Ming-Chun Chiu
  •  & Lee-Yung Shih

• Article
  03 February 2020 | Open Access

  SCF^β-TrCP-mediated degradation of TOP2β promotes cancer cell survival in response to chemotherapeutic drugs targeting topoisomerase II

  • Jianfeng Shu
  • , Danrui Cui
  •  & Yongchao Zhao

• Article
  02 January 2020 | Open Access

  DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells

  • Joo-Young Im
  • , Bo-Kyung Kim
  •  & Misun Won